Oncology dealmaking fell sharply in 2024, in terms of overall value and number of deals. The ~$90 billion worth of cancer-focused licensing and merger and acquisition (M&A) transactions in 2024 ...

New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression. The ...